Researchers from Baltimore-based Johns Hopkins Medicine led the study, according to a Feb. 26 news release from the health system.
The study authors are suggesting that oral prednisone, frequently used to treat heart inflammation, be used sparingly in patients with lupus to lower the risk of pericarditis recurrence.
Read the full study here.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
